Article
Preclinical safety profile of plasma prepared using the INTERCEPT Blood System.
Vox sanguinis - 1 Oct 2003
Ciaravino V, McCullough T, Cimino G, Sullivan T
Abstract excerpt
BACKGROUND AND OBJECTIVES: The newly developed INTERCEPT Blood System for plasma uses the addition of a new psoralen, amotosalen HCl (AMOTOSALEN), followed by illumination with ultraviolet A light, to inactivate viruses, bacteria, protozoa and leucocytes that may contaminate fresh-frozen plasma (...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
